BARD buy safety needle

The IV device market continues to  consolidate as BARD pay $68 million for Specialized Health Products International Inc… the company primarily make safety needles for the intravenous chemotherapy market.

“The deal represents a good fit, in our view, and should be neutral to earnings in 2008,” said Lehman Brothers analyst Bob Hopkins, in a note to investors.Click here for the full story. 

Other stories